The Space Between Manufacturing & Market Article # 2: Compliance Isn't Commercialization - Understanding the Missing Link

In regulated environments, there is a strong focus on doing things the right way. Processes are followed, documentation is maintained, and systems are controlled to ensure consistency and traceability. Products are developed with careful attention to quality, often aligned to standards like ISO 13485. From a manufacturing and quality perspective, that work is essential. It creates structure, accountability, and confidence in what is being built.

But something I’ve been starting to question is whether doing everything “right” from a compliance standpoint actually guarantees that a product will succeed once it reaches the market. From what I’m learning, the answer is no. Compliance and commercialization are closely related, but they are not the same thing.

Compliance is about meeting requirements. It focuses on ensuring that a product is safe, properly documented, and built according to established processes. It answers questions about whether procedures were followed, whether standards were met, and whether the product is ready to be released. Commercialization, on the other hand, is about what happens after that point. It shifts the focus to whether the product is adopted, used, and sustained in the real world. It introduces a different set of questions; whether the product fits into existing workflows, whether it delivers value in practice, and whether it will actually be paid for.

That last point is one I didn’t fully appreciate before. Even if a device is well-built and meets all regulatory expectations, it still needs to be reimbursed in order to be widely used. Organizations like the Centers for Medicare & Medicaid Services (CMS) play a major role in determining whether that happens. Without reimbursement, adoption becomes significantly more difficult, regardless of how strong the product is from a manufacturing standpoint. This is where the gap between compliance and commercialization starts to become more visible.

From inside a regulated environment, success can feel clearly defined. If a product meets requirements and moves through the system correctly, it is considered ready. But once it leaves that environment, a completely different set of conditions begins to shape its outcome. Those conditions don’t always align with how the product was designed, developed, or validated. A device can be compliant, well-documented, and manufactured with precision, yet still struggle because it doesn’t fit into how care is delivered or because the financial side of using it hasn’t been fully addressed. Not because something went wrong, but because something wasn’t connected.

From where I sit, most of the focus is on ensuring the product is built correctly, and that makes sense. That is what regulated systems are designed to do. But what I’m starting to realize is that building correctly is only part of the picture. There are other factors that ultimately determine whether a product succeeds, and they aren’t always visible within manufacturing or quality systems. It raises a broader question about whether commercialization should be considered earlier in the process, rather than being treated as something that happens after a product is complete.

I don’t have a complete answer to that, but it does seem like there is value in understanding how these pieces connect. Compliance supports commercialization, but it doesn’t replace it. And if the goal is not just to build products, but to see them actually used, then both sides of that equation matter. This is something I’ll continue exploring throughout this series, looking at where these gaps exist and how they might be better understood.

#MedTech #RegulatedIndustry #QualitySystems #ISO13485 #Commercialization #Reimbursement #HealthcareInnovation #Governance #DataIntegrity #DigitalTransformation #eQMS #BridgingTheGap

Katie Casteel works in a regulated medical device environment and is currently pursuing a PhD in Information Technology with a cyber engineering focus. Her research interests include IT governance, cybersecurity, and organizational risk management.

This article is part of The Space Between Manufacturing & Market series, which explores the gap between building compliant, high-quality products and achieving real-world success in the market.